Pharma Lobby Changes Rules, Loses 22 Pharma Firms

May 11, 2017

The pharma industry’s powerful Washington, D.C. trade association decreased by nearly two dozen companies after changing its membership rules amid the debate over U.S. drug prices, according to a Bloomberg article.

Pharmaceutical Research and Manufacturers of America (PhRMA) will require that members spend at least $200 million a year on research and development and that their R&D spending is at least 10 percent of global sales. The changes follow a three-month review that has already seen several member companies leave the lobbying group, the story said.

Read the full article